Coloplast to issue notes for EUR 3.5bn

The medtech firm has announced that it is establishing a program to sell senior unsecured notes for up to EUR 3.5bn, aiming to finance the acquisition of Atos Medical.
Photo: Coloplast / PR
Photo: Coloplast / PR
by ulrich quistgaard, translated by daniel pedersen

Coloplast is on the hunt for capital, and has prepared for this by establishing a Euro Medium Term Note (EMTN) program, the company has announced in a notification.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading